A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors
Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not be...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db1d50ff15464faf850ae9a02d2d5992 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:db1d50ff15464faf850ae9a02d2d5992 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:db1d50ff15464faf850ae9a02d2d59922021-11-29T00:55:43ZA Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors2314-614110.1155/2021/5862941https://doaj.org/article/db1d50ff15464faf850ae9a02d2d59922021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5862941https://doaj.org/toc/2314-6141Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not been reported yet. Here, for the first time, we investigated the potential oncogenic and prognostic role of CKS1B across 33 tumors based on public databases and further verified it in a small scale by RNA sequencing or quantitative real-time PCR. CKS1B was generally highly expressed in a majority of tumors and had a notable correlation with the prognosis of patients, but its prognostic significance in different tumors was not exactly the same. In addition, CKS1B expression was also closely related to the infiltration of cancer-associated fibroblasts in tumors such as breast invasive carcinoma, kidney chromophobe, lung adenocarcinoma, and tumor-infiltrating lymphocytes in tumors such as glioblastoma multiforme, bladder urothelial carcinoma, and brain lower grade glioma. Moreover, reduced CKS1B methylation was observed in certain tumors, for example, adrenocortical carcinoma. Cell cycle and kinase activity regulation and PI3K-Akt signaling pathway were found to be involved in the functional mechanism of CKS1B. In conclusion, our first pan-cancer analysis of CKS1B contributes to a better overall understanding of CKS1B and may provide a new target for future cancer therapy.Yan JiaQuan TianKaitai YangYi LiuYanfeng LiuHindawi LimitedarticleMedicineRENBioMed Research International, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Yan Jia Quan Tian Kaitai Yang Yi Liu Yanfeng Liu A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
description |
Although more and more evidence supports CDC28 protein kinase subunit 1B (CKS1B) is involved significantly in the development of human cancers, most of the researches have focused on a single disease, and pan-cancer studies conducted from a holistic perspective of different tumor sources have not been reported yet. Here, for the first time, we investigated the potential oncogenic and prognostic role of CKS1B across 33 tumors based on public databases and further verified it in a small scale by RNA sequencing or quantitative real-time PCR. CKS1B was generally highly expressed in a majority of tumors and had a notable correlation with the prognosis of patients, but its prognostic significance in different tumors was not exactly the same. In addition, CKS1B expression was also closely related to the infiltration of cancer-associated fibroblasts in tumors such as breast invasive carcinoma, kidney chromophobe, lung adenocarcinoma, and tumor-infiltrating lymphocytes in tumors such as glioblastoma multiforme, bladder urothelial carcinoma, and brain lower grade glioma. Moreover, reduced CKS1B methylation was observed in certain tumors, for example, adrenocortical carcinoma. Cell cycle and kinase activity regulation and PI3K-Akt signaling pathway were found to be involved in the functional mechanism of CKS1B. In conclusion, our first pan-cancer analysis of CKS1B contributes to a better overall understanding of CKS1B and may provide a new target for future cancer therapy. |
format |
article |
author |
Yan Jia Quan Tian Kaitai Yang Yi Liu Yanfeng Liu |
author_facet |
Yan Jia Quan Tian Kaitai Yang Yi Liu Yanfeng Liu |
author_sort |
Yan Jia |
title |
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
title_short |
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
title_full |
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
title_fullStr |
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
title_full_unstemmed |
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors |
title_sort |
pan-cancer analysis of clinical prognosis and immune infiltration of cks1b in human tumors |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/db1d50ff15464faf850ae9a02d2d5992 |
work_keys_str_mv |
AT yanjia apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT quantian apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT kaitaiyang apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT yiliu apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT yanfengliu apancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT yanjia pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT quantian pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT kaitaiyang pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT yiliu pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors AT yanfengliu pancanceranalysisofclinicalprognosisandimmuneinfiltrationofcks1binhumantumors |
_version_ |
1718407802252165120 |